Articles

The glucose-reducing drug empagliflozin (Jardiance) won approval today from the US Food and Drug Administration (FDA) after Boehringer Ingelheim corrected manufacturing problems that caused the agency to say "no" in March…. 

Beta cell encapsulation therapy is a procedure that involves implantation of cells with the ability to secrete insulin in a glucose-responsive manner in a protective barrier into the body…. On July 17th 2014, the Juvenile Diabetes Research Foundation (JDRF) announced that their partner, ViaCyte, Inc. filed an Investigational New Drug …

Previous studies have shown that decreasing postprandial hyperglycemia with acarbose could reduce the risk of CV events but a new study shows that risk may increase for the first 12 months of exposure…. 

Adjusted mean DBP levels found to be significantly higher in women compared to men but other risk factors were almost the same between genders….

The best outcomes were achieved by multiple daily injections with self-monitoring of blood glucose…. 

A new delivery system has been evaluated and found to be safe and effective for young adults to use at home without any supervision needed….

Better overall lipid effects were seen in type 2 diabetes patients with coronary artery disease treated with metformin than those being treated with glipizide….

A total daily insulin dose of about 0.2 U/kg was optimal to cover the fast day, "although there is considerable variability between patients."…

A peptide called caerulein converted existing cells in the pancreas into insulin-generating beta cells….

Adequate glycemic control is 48% and health insurance coverage among Latino diabetics is 52.4%….